Movano Inc (MOVE) Stock Price, Quote & News

Company Profile

Movano Inc., a technology company, engages in the development of a platform to deliver healthcare solutions at the intersection of medical and consumer devices. It offers Evie Ring, a wearable device for women that combines health and wellness metrics comprising resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps...

Industry: Medical Devices

Sector: Healthcare

Phone: 415 651 3172

Website: movano.com

Address:

6800 Koll Center Parkway, Pleasanton, United States

Bazzzigar Feb. 3 at 6:59 PM

$MOVE moved to BBNX

1 · Reply

StocksVol17 Feb. 3 at 6:04 PM

$MOVE Any hope?

0 · Reply

frangoGnarly Feb. 3 at 1:57 PM

$MOVE

0 · Reply

Nickleanddime Feb. 3 at 1:13 PM

$MOVE moving into the 20s today

1 · Reply

Yuky Feb. 3 at 9:23 AM

$MOVE 🚀🚀🚀🚀

0 · Reply

pAmdd Feb. 2 at 7:27 PM

$MOVE still holding my short from 19

0 · Reply

EmSol Feb. 2 at 6:47 PM

$MOVE halted for 1 h

0 · Reply

frangoGnarly Feb. 2 at 5:44 PM

$MOVE

0 · Reply

EmSol Feb. 2 at 5:33 PM

$MOVE let’s drop to $12 and load, it’s black Monday

0 · Reply

bowlerhatsftw Feb. 2 at 5:21 PM

$MOVE halted

0 · Reply

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Movano Inc. (MOVE)

Jan 22, 2026, 4:05 PM EST - 12 days ago

Corvex Secures Long-Term NVIDIA H200 GPU Deployment with AI-driven Provider of High-Performance Battery Technologies to Support Production AI Workloads

Nov 27, 2025, 6:42 PM EST - 2 months ago

Halper Sadeh LLC Encourages MOVE and GIFI Shareholders to Contact the Firm to Discuss Their Rights

GIFI

Nov 10, 2025, 1:08 PM EST - 3 months ago

GLTO, MOVE: two penny stocks quadrupled today – but should you buy?

GLTO

Nov 10, 2025, 7:30 AM EST - 3 months ago

CORVEX TO GO PUBLIC IN ALL-STOCK MERGER WITH MOVANO, CREATING A PURE-PLAY PLATFORM FOR SECURE AI INFRASTRUCTURE AND HIGH-PERFORMANCE INFERENCE

Oct 8, 2025, 8:30 AM EDT - 4 months ago

Movano Health Announces Reverse Stock Split

Aug 28, 2025, 4:30 PM EDT - 5 months ago

Movano Health Granted Listing Extension by Nasdaq

Aug 22, 2025, 4:15 PM EDT - 5 months ago

Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

Jul 11, 2025, 5:30 PM EDT - 7 months ago

Movano Health Plans to Timely Request a Hearing Before a Nasdaq Hearings Panel

May 16, 2025, 4:30 PM EDT - 9 months ago

Movano Health's Board of Directors Initiates Process to Maximize Shareholder Value

Apr 22, 2025, 8:00 AM EDT - 10 months ago

Movano Health's Proprietary Cuffless Blood Pressure Device Once Again Achieves Accuracy Commensurate with the FDA's Requirements

Mar 10, 2025, 8:00 AM EDT - 11 months ago

Movano's Evie Ring Adds New Personalization and Trend Tracking to Support Women's Wellness Journey

Feb 4, 2025, 8:00 AM EST - 1 year ago

Movano Health Commences Clinical Study with New Cuffless Blood Pressure Device

Jan 8, 2025, 8:00 AM EST - 1 year ago

Movano Health Launches EvieAI Virtual Wellness Assistant

Jan 2, 2025, 8:00 AM EST - 1 year ago

Movano Health Welcomes Dr. Shaheen Wirk to its Board of Directors

Dec 2, 2024, 9:22 AM EST - 1 year ago

Movano Health Receives FDA Clearance for EvieMED Ring

Nov 14, 2024, 9:57 PM EST - 1 year ago

Movano Inc. (MOVE) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 4:05 PM EST - 1 year ago

Movano Health Reports Q3 2024 Financial Results and Provides Business Update

Nov 7, 2024, 8:00 AM EST - 1 year ago

Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device

Nov 6, 2024, 8:00 AM EST - 1 year ago

Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024

Nov 4, 2024, 8:00 AM EST - 1 year ago

Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split

Nov 4, 2024, 8:00 AM EST - 1 year ago

Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED

Oct 31, 2024, 8:30 AM EDT - 1 year ago

Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split

Oct 30, 2024, 9:00 AM EDT - 1 year ago

Evie Ring Announces Brand Partnership with Lifestyle Content Creator Heidi D'Amelio

Oct 24, 2024, 8:00 AM EDT - 1 year ago

Movano Health Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase

Oct 10, 2024, 8:00 AM EDT - 1 year ago

Movano Health Provides Update on FDA Review of EvieMED Ring

Sep 17, 2024, 8:00 AM EDT - 1 year ago

Evie, Movano Health's Smart Ring for Women, is Back In Stock with Key Upgrades

Sep 3, 2024, 8:00 AM EDT - 1 year ago

Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring

Aug 14, 2024, 7:38 PM EDT - 1 year ago

Movano Inc. (MOVE) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:05 PM EDT - 1 year ago

Movano Health Reports Q2 2024 Financial Results and Provides Business Update

Aug 5, 2024, 9:00 AM EDT - 1 year ago

Movano Health Provides Progress Update on EvieMED Regulatory Filing

Aug 5, 2024, 9:00 AM EDT - 1 year ago

Movano Health to Report Second Quarter 2024 Financial Results on Wednesday August 14, 2024

Jun 28, 2024, 9:00 AM EDT - 1 year ago

Movano Health Announces Dr. Fatima Rodriguez Joining July 11 Virtual Event

Jun 13, 2024, 9:00 AM EDT - 1 year ago

Movano Health Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion

Jun 10, 2024, 9:00 AM EDT - 1 year ago

MIT Selects Movano Health for Groundbreaking Study on Long COVID and Chronic Lyme Disease

May 15, 2024, 7:05 PM EDT - 1 year ago

Movano Inc. (MOVE) Q1 2024 Earnings Call Transcript

May 15, 2024, 4:05 PM EDT - 1 year ago

Movano Health Reports Q1 2024 Financial Results and Provides Business Update

May 9, 2024, 8:00 AM EDT - 1 year ago

Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision

May 6, 2024, 5:00 PM EDT - 1 year ago

Movano Health to Report First Quarter 2024 Financial Results on Wednesday May 15, 2024

Apr 10, 2024, 10:23 AM EDT - 1 year ago

Movano Inc. (MOVE) Q4 2023 Earnings Call Transcript

Apr 5, 2024, 8:00 AM EDT - 1 year ago

Movano Health Closes $24 Million Private Placement

Apr 4, 2024, 4:30 PM EDT - 1 year ago

Movano Health Reports 2023 Financial Results and Provides Business Update

Apr 2, 2024, 5:01 PM EDT - 2 years ago

Movano Health Announces $24 Million Private Placement

Apr 2, 2024, 5:00 PM EDT - 2 years ago

Movano Health Secures Strategic Investment from Tier-One Multi-Billion Dollar Medical Device Company

Apr 2, 2024, 4:05 PM EDT - 2 years ago

Movano Health to Report Fourth Quarter 2023 Financial Results on Thursday, April 4, 2024

Jan 22, 2024, 8:00 AM EST - 2 years ago

Movano Health Announces Evie Rings Now Shipping

Jan 9, 2024, 8:00 AM EST - 2 years ago

Movano Health and ams OSRAM Collaborate to Deliver Accurate Lifestyle Monitoring Solutions for Women

Jan 8, 2024, 7:00 AM EST - 2 years ago

Evie, the First Women-Focused Health Ring, Takes 'Smart' to a New Level

Dec 18, 2023, 8:00 AM EST - 2 years ago

Movano Health Announces HSA/FSA Eligibility for its Women First Wearable, The Evie Ring

Bazzzigar Feb. 3 at 6:59 PM

$MOVE moved to BBNX

1 · Reply

StocksVol17 Feb. 3 at 6:04 PM

$MOVE Any hope?

0 · Reply

frangoGnarly Feb. 3 at 1:57 PM

$MOVE

0 · Reply

Nickleanddime Feb. 3 at 1:13 PM

$MOVE moving into the 20s today

1 · Reply

Yuky Feb. 3 at 9:23 AM

$MOVE 🚀🚀🚀🚀

0 · Reply

pAmdd Feb. 2 at 7:27 PM

$MOVE still holding my short from 19

0 · Reply

EmSol Feb. 2 at 6:47 PM

$MOVE halted for 1 h

0 · Reply

frangoGnarly Feb. 2 at 5:44 PM

$MOVE

0 · Reply

EmSol Feb. 2 at 5:33 PM

$MOVE let’s drop to $12 and load, it’s black Monday

0 · Reply

bowlerhatsftw Feb. 2 at 5:21 PM

$MOVE halted

0 · Reply

Batman_the_legend Feb. 2 at 5:17 PM

$IBIO The roaring Lion picked IBIO under $1.10 now just started $DRMA at strong buy 10x . Buy a little if you can. sold $MOVE in $EVTV https://www.moomoo.com/stock/DRMA-US/community?_ftsdk=1767210349494147&_fttime=1770051441&chain_id=f37s0EKZJEb-h4.1ko1lpm&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A27%7D

2 · Reply

invest01 Feb. 1 at 3:29 PM

$BNAI same situation with $MOVE , also low float and high gumper. Looks like "they" want to scare retail or something with ticker gone... :))) it means shorts are desperate.

0 · Reply

Bazzzigar Jan. 31 at 3:23 PM

$MOVE ABT

0 · Reply

StocksVol17 Jan. 31 at 12:44 AM

So currently my shares aree as below: $BNAI @23.3 $MOVE @21.1 $ELPW @4.56 Down 2k$ Any hope?

2 · Reply

IndianTech Jan. 30 at 8:55 PM

$VIVS is going parabolic now. AH epic run higher. $MOVE $TCGL $SMX

2 · Reply

IndianTech Jan. 30 at 8:35 PM

$VIVS is mooning AH. Just like $TCGL $MOVE $SMX

0 · Reply

OX50 Jan. 30 at 7:47 PM

$MOVE

0 · Reply

pAmdd Jan. 30 at 7:16 PM

$MOVE added 2k more, now holding sizable position short. This was great week made money being long and short here. Longs have to remember one lesson from here when stock goes from 20 to 35 and it closes 20 it is over

0 · Reply

pAmdd Jan. 30 at 6:24 PM

$MOVE already nice profit should be 12 mos week

0 · Reply

T45020 Jan. 30 at 4:54 PM

$MOVE I bet it we all put $50 sell orders on our holdings this would fly like TCGL and their 4 million shares that were $8.80 just yesterday. Here we have only 1 million. Good luck.

0 · Reply

Money__Hunter Jan. 30 at 4:52 PM

$MOVE $MOVE I am so curious how MMs choose which stock to pump and which ones not to. Like why they decided to pump TCGl and ELPW to 1000%+ percent, but decided to put a hard stop on MOVE hich has far less float than any of those two stock. Like who said MOVE must not cross 30$, but TCGL has to go to 500.

0 · Reply

OX50 Jan. 30 at 4:49 PM

$MOVE Latest Report 01/29/2026 LSEG maintains a current price target of $30 for MOVE

0 · Reply

Market Cap	14.30M
Revenue (ttm)	1.01M
Net Income (ttm)	-23.73M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-2,349.50%
Debt to Equity Ratio	-1.75

Volume	145,000
Avg Vol	1,230,548
Day's Range	N/A - N/A
Shares Out	835,000.00
Stochastic %K	23%
Beta	0.79
Analysts	Strong Buy
Price Target	$29.99